EquityZen Growth Technology Fund LLC - Series 1321
Raised
$370K
Investors
6
Min Invest
$17,627
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1321 is a Delaware pooled investment fund filed by EquityZen Advisors LLC on 2022-07-06, raising $370K from 6 investors under Rule 506(b) and Section 3(c)(1) exemptions. The fund requires an $18K minimum investment and is part of EquityZen's pre-IPO investment platform, which operates nearly 1,900 series vehicles providing access to private company equity.
This pre-IPO pooled investment fund uses the standard 506(b)/3(c)(1) exemption structure typical of EquityZen's series vehicle model. The $18K minimum investment represents a relatively accessible entry point for accredited investors seeking exposure to private growth-stage technology companies, consistent with the platform's retail-accredited positioning in the secondary market segment.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
